Characterization of the Human Cervical Mucous Proteome.
INTRODUCTION: Cervical cancer is among the most common cancers in women worldwide. Discovery of biomarkers for the early detection of cervical cancer would improve current screening practices and reduce the burden of disease. OBJECTIVE: In this study, we report characterization of the human cervical mucous proteome as the first step towards protein biomarker discovery. METHODS: The protein composition was characterized using one- and two-dimensional gel electrophoresis, and liquid chromatography coupled with mass spectrometry. We chose to use this combination of traditional biochemical techniques and proteomics to allow a more comprehensive analysis. RESULTS AND CONCLUSION: A total of 107 unique proteins were identified, with plasma proteins being most abundant. These proteins represented the major functional categories of metabolism, immune response, and cellular transport. Removal of high molecular weight abundant proteins by immunoaffinity purification did not significantly increase the number of protein spots resolved. We also analyzed phosphorylated and glycosylated proteins by fluorescent post-staining procedures. The profiling of cervical mucous proteins and their post-translational modifications can be used to further our understanding of the cervical mucous proteome.
Panicker
Gitika
G
Ye
Yiming
Y
Wang
Dongxia
D
Unger
Elizabeth R
ER
Electrophoresis. 1999 Feb;20(2):362-71
10197444
J Proteomics. 2009 Jan 30;71(6):637-46
19064004
Gynecol Oncol. 2005 Oct;99(1):26-35
16051329
Eur J Biochem. 2001 Oct;268(19):5001-10
11589691
Cancer Lett. 2005 Nov 18;229(2):245-52
16112431
Clin Obstet Gynecol. 1981 Jun;24(2):355-77
7030563
Proteomics. 2003 Jul;3(7):1128-44
12872214
J Proteome Res. 2007 Jul;6(7):2859-65
17567164
Cell Res. 2005 Apr;15(4):237-46
15857578
Glycobiology. 2007 Dec;17(12):1344-56
17884841
J Proteome Res. 2007 Apr;6(4):1258-68
17373839
J Proteome Res. 2007 Jan;6(1):89-96
17203952
Clin Diagn Lab Immunol. 2000 Jan;7(1):45-8
10618275
J Proteome Res. 2007 Jul;6(7):2874-83
17539673
Br J Cancer. 2009 Apr 21;100(8):1303-14
19367286
J Proteome Res. 2004 May-Jun;3(3):364-82
15253417
J Carcinog. 2008 Jul 17;7:2
18637184
Clin Cancer Res. 2005 Jul 15;11(14):5146-52
16033829
Int J Cancer. 2005 May 20;115(1):114-20
15688414
Adv Exp Med Biol. 1982;144:301-18
7044063
Reprod Sci. 2008 Apr;15(3):263-73
18421021
Physiol Rev. 2008 Jan;88(1):1-35
18195081
Glycobiology. 2008 Jan;18(1):2-8
17956937
J Immunol. 2005 Jun 1;174(11):7257-67
15905572
Cancer Res. 2008 Oct 1;68(19):7811-8
18829536
Proc Natl Acad Sci U S A. 2009 Apr 28;106(17):6950-5
19359471
Genome Biol. 2003;4(5):P3
12734009
Mol Cell Proteomics. 2008 Aug;7(8):1420-33
18426791
Eur J Surg Oncol. 2008 Apr;34(4):357-64
17566693
J Proteome Res. 2005 Nov-Dec;4(6):2236-42
16335971
Biochem J. 1995 Sep 15;310 ( Pt 3):1053-4
7575402
Aust N Z J Obstet Gynaecol. 2007 Feb;47(1):9-15
17261093
Cell Stress Chaperones. 2005 Summer;10(2):86-103
16038406
J Proteome Res. 2007 Apr;6(4):1269-76
17373840
Mol Cell Proteomics. 2007 Apr;6(4):708-16
17220477
Mol Cell Proteomics. 2006 Nov;5(11):2167-74
16854842
Hum Reprod Update. 1999 Jul-Aug;5(4):280-92
10465520
Proteomics. 2001 Jul;1(7):841-55
11503209